CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jul 21, 2015
Insider Transaction Report
Form 4
von Emster Kurt
Director
Transactions
- Purchase
Common Stock
2015-07-20$2.81/sh+1,600,000$4,496,000→ 1,600,000 total(indirect: See footnote)
Holdings
- 17,326(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Consists of (i) 533,333 shares held by Abingworth Bioventures VI, LP ("ABV VI"), and (ii) 1,066,667 shares held by Abingworth Bioequities Master Fund Limited ("ABE," and collectively with ABV VI, the "Abingworth Funds").
- [F2]Abingworth LLP ("ALLP") provides advisory services to the Abingworth Funds. Kurt von Emster ("Emster") is a member of ALLP. Emster may be deemed the indirect beneficial owner of the shares through his indirect interest in the Abingworth Funds. Emster disclaims beneficial ownership of the shares except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that ALLP, the Abingworth Funds, Emster or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.